Research Program Cancer

Speaker: Prof. Dr. Claus Scheidereit

The MDC Cancer Research Program consists of a group of respected scientific laboratories which work in the fields of signal transduction and growth control, structural genome research, and tumor immunology. Studies on the emergence of cancer are being conducted in close collaboration with the research groups of the MDC and the clinically-oriented groups of the Robert-Rössle Cancer Clinic of the Charité/Humboldt-University in Berlin, and the Helios-Clinic. The objectives are to understand the development and the progression of cancer diseases through excellent basic research at the molecular level, to develop improved diagnostics, and finally to utilize the gained knowledge for the development of new treatments 

 

Signalling Pathways, Cell Biology and Cancer

(Prof. Dr. Achim Leutz)


Clinical and Molecular Oncology

( Prof. Dr. Peter Daniel )

Intracellular Proteolysis

( Prof. Dr. Thomas Sommer )

Signal Transduction in Tumor Cells

( Prof. Dr. Claus Scheidereit )

Surgical Oncology

( Prof. Dr. Peter M. Schlag )


Structural and Functional Genomics

(Prof. Dr. Udo Heinemann)


Macromolecular Structure and Interaction

( Prof. Dr. Udo Heinemann )


Tumor Immunology

(Dr. Martin Lipp)


Experimental Pharmacology

( Dr. Iduna Fichtner )

Haematoloy, Oncology and Tumorimmunology

( Prof. Dr. Bernd Doerken )

Molecular Cell Biology and Gene Therapy

( Prof. Dr. Wolfgang Uckert )

Molecular Immunology and Gene Therapy

( Prof. Dr. Thomas Blankenstein )

Molecular Immunotherapy

( Prof. Dr. Antonio Pezzutto )